Classical methods and perspectives for manipulating the human gut microbial ecosystem

References

• Abbaszadegan, A., Y. Ghahramani, A. Gholami, B. Hemmateenejad, S. Dorostkar, M. Nabavizadeh, and H. Sharghi. 2015. The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: A preliminary study. Journal of Nanomaterials 2015:1–8. doi: 10.1155/2015/720654.
   Web of Science ®Google Scholar
• Abedon, S. T., C. Thomas-Abedon, A. Thomas, and H. Mazure. 2011. Bacteriophage prehistory: Is or is not Hankin, 1896, a phage reference? Bacteriophage 1 (3):174–8. doi: 10.4161/bact.1.3.16591.
   PubMedGoogle Scholar
• Ageitos, J. M., A. Sánchez-Pérez, P. Calo-Mata, and T. G. Villa. 2017. Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria. Biochemical Pharmacology 133:117–38. doi: 10.1016/j.bcp.2016.09.018.
   PubMed Web of Science ®Google Scholar
• Alderete, T. L., C. Autran, B. E. Brekke, R. Knight, L. Bode, M. I. Goran, and D. A. Fields. 2015. Associations between human milk oligosaccharides and infant body composition in the first 6 mo of life. American Journal of Clinical Nutrition 102 (6):1381–8. doi: 10.3945/ajcn.115.115451.
   PubMed Web of Science ®Google Scholar
• Alexander, J. L., I. D. Wilson, J. Teare, J. R. Marchesi, J. K. Nicholson, and J. M. Kinross. 2017. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology & Hepatology 14:356. doi: 10.1038/nrgastro.2017.20.
   PubMed Web of Science ®Google Scholar
• Aliasgharzadeh, A., M. Khalili, E. Mirtaheri, B. Pourghassem Gargari, F. Tavakoli, M. Abbasalizad Farhangi, H. Babaei, and P. Dehghan. 2015. A combination of prebiotic inulin and oligofructose improve some of cardiovascular disease risk factors in women with type 2 diabetes: A randomized controlled clinical trial. Advanced Pharmaceutical Bulletin 5 (4):507–14. doi: 10.15171/apb.2015.069.
   PubMed Web of Science ®Google Scholar
• Alkaya, B., I. Laleman, S. Keceli, O. Ozcelik, M. Cenk Haytac, and W. Teughels. 2017. Clinical effects of probiotics containing Bacillus species on gingivitis: A pilot randomized controlled trial. Journal of Periodontal Research 52 (3):497–504. doi: 10.1111/jre.12415.
   PubMed Web of Science ®Google Scholar
• Altenhoefer, A., S. Oswald, U. Sonnenborn, C. Enders, J. Schulze, J. Hacker, and T. A. Oelschlaeger. 2004. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunology and Medical Microbiology 40 (3):223–9. doi: 10.1016/S0928-8244(03)00368-7.
   PubMedGoogle Scholar
• Anand, G., A. Zarrinpar, and R. Loomba. 2016. Targeting dysbiosis for the treatment of liver disease. Seminars in Liver Disease 36 (1):37–47. doi: 10.1055/s-0035-1571276.
   PubMed Web of Science ®Google Scholar
• Ang, L., S. Arboleya, G. Lihua, Y. Chuihui, Q. Nan, M. Suarez, G. Solís, C. G. de los Reyes-Gavilán, and M. Gueimonde. 2015. The establishment of the infant intestinal microbiome is not affected by rotavirus vaccination. Scientific Reports 4 (1):7417. doi: 10.1038/srep07417.
   Google Scholar
• Anhê, F. F., D. Roy, G. Pilon, S. Dudonné, S. Matamoros, T. V. Varin, C. Garofalo, Q. Moine, Y. Desjardins, E. Levy, et al. 2015. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64 (6):872–83. doi: 10.1136/gutjnl-2014-307142.
   PubMed Web of Science ®Google Scholar
• Ansari, M. A., H. M. Khan, A. A. Khan, M. K. Ahmad, A. A. Mahdi, R. Pal, and S. S. Cameotra. 2014. Interaction of silver nanoparticles with Escherichia coli and their cell envelope biomolecules. Journal of Basic Microbiology 54 (9):905–15. doi: 10.1002/jobm.201300457.
   PubMed Web of Science ®Google Scholar
• Arrizon, J. H.-M., A. Toksoy Oner, and M. Gonzalez-Avila. 2014. In vitro prebiotic activity of fructans with different fructosyl linkage for symbiotics elaboration. International Journal of Probiotics and Prebiotics 9 (3):69–76. doi: 10.1002/mds.20216.
   Google Scholar
• Bäckhed, F., R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon. 2005. Host-bacterial mutualism in the human intestine. Science 307 (5717):1915–20. doi: 10.1126/science.1104816.
   PubMed Web of Science ®Google Scholar
• Bahr, S. M., B. C. Tyler, N. Wooldridge, B. D. Butcher, T. L. Burns, L. M. Teesch, C. L. Oltman, M. A. Azcarate-Peril, J. R. Kirby, and C. A. Calarge. 2015. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Translational Psychiatry 5 (10):e652. doi: 10.1038/tp.2015.135.
   PubMedGoogle Scholar
• Bakken, J. S., T. Borody, L. J. Brandt, J. V. Brill, D. C. Demarco, M. A. Franzos, C. Kelly, A. Khoruts, T. Louie, L. P. Martinelli, et al. 2011. Treating clostridium difficile infection with fecal microbiota transplantation. Clinical Gastroenterology and Hepatology 9 (12):1044–9. doi: 10.1016/j.cgh.2011.08.014.
   PubMed Web of Science ®Google Scholar
• Balamurugan, R., E. Rajendiran, S. George, G. V. Samuel, and B. S. Ramakrishna. 2008. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, desulfovibrio and enterococcus faecalis in the feces of patients with colorectal cancer. Journal of Gastroenterology and Hepatology 23 (8pt1):1298–303. doi: 10.1111/j.1440-1746.2008.05490.x.
   PubMedGoogle Scholar
• Barea, M. J., M. J. Jenkins, Y. S. Lee, P. Johnson, and R. H. Bridson. 2012. Encapsulation of liposomes within PH responsive microspheres for oral colonic drug delivery. International Journal of Biomaterials 2012:1–8. doi: 10.1155/2012/458712.
   Google Scholar
• Baümler, A. J., and V. Sperandio. 2016. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535 (7610):85–93. doi: 10.1038/nature18849.
   PubMed Web of Science ®Google Scholar
• Becattini, S., Y. Taur, and E. G. Pamer. 2016. Antibiotic-induced changes in the intestinal microbiota and disease. Trends in Molecular Medicine 22 (6):458–78. doi: 10.1016/j.molmed.2016.04.003.
   PubMed Web of Science ®Google Scholar
• Becker, J. C., N. Grosser, C. Waltke, S. Schulz, K. Erdmann, W. Domschke, H. Schröder, and T. Pohle. 2006. Beyond gastric acid reduction: Proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochemical and Biophysical Research Communications 345 (3):1014–21. doi: 10.1016/j.bbrc.2006.04.170.
   PubMed Web of Science ®Google Scholar
• Benjamin, E. J., P. Muntner, A. Alonso, M. S. Bittencourt, C. W. Callaway, A. P. Carson, A. M. Chamberlain, A. R. Chang, S. Cheng, S. R. Das, et al. 2019. Heart disease and stroke statistics—2019 update: A report from the American Heart Association. Circulation 139 (10):e56–528. doi: 10.1161/CIR.0000000000000659.
   PubMed Web of Science ®Google Scholar
• Berer, K., L. A. Gerdes, E. Cekanaviciute, X. Jia, L. Xiao, Z. Xia, C. Liu, L. Klotz, U. Stauffer, S. E. Baranzini, et al. 2017. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proceedings of the National Academy of Sciences 114 (40):10719–24. doi: 10.1073/pnas.1711233114.
   PubMed Web of Science ®Google Scholar
• Berer, K., M. Mues, M. Koutrolos, Z. A. Rasbi, M. Boziki, C. Johner, H. Wekerle, and G. Krishnamoorthy. 2011. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479 (7374):538–41. doi: 10.1038/nature10554.
   PubMed Web of Science ®Google Scholar
• Berg, R. D. 1996. The indigenous gastrointestinal microflora. Trends in Microbiology 4 (11):430–5. doi: 10.1016/0966-842X(96)10057-3.
   PubMed Web of Science ®Google Scholar
• Berni Canani, R., M. Di Costanzo, and L. Leone. 2012. The epigenetic effects of butyrate: Potential therapeutic implications for clinical practice. Clinical Epigenetics 4 (1):4. doi: 10.1186/1868-7083-4-4.
   PubMed Web of Science ®Google Scholar
• Bikard, D., C. W. Euler, W. Jiang, P. M. Nussenzweig, G. W. Goldberg, X. Duportet, V. A. Fischetti, and L. A. Marraffini. 2014. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nature Biotechnology 32 (11):1146–50. doi: 10.1038/nbt.3043.
   PubMed Web of Science ®Google Scholar
• Boisseau, P., and B. Loubaton. 2011. Nanomedicine, nanotechnology in medicine. Comptes Rendus Physique 12 (7):620–36. doi: 10.1016/j.crhy.2011.06.001.
   Web of Science ®Google Scholar
• Bondarenko, O., K. Juganson, A. Ivask, K. Kasemets, M. Mortimer, and A. Kahru. 2013. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Archives of Toxicology 87 (7):1181–200. doi: 10.1007/s00204-013-1079-4.
   PubMed Web of Science ®Google Scholar
• Breyner, N. M., C. Michon, C. S. de Sousa, P. B. Vilas Boas, F. Chain, V. A. Azevedo, P. Langella, and J. M. Chatel. 2017. Microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-ΚB pathway. Frontiers in Microbiology 8:114. doi: 10.3389/fmicb.2017.00114.
   PubMed Web of Science ®Google Scholar
• Brown, A. J., S. M. Goldsworthy, A. A. Barnes, M. M. Eilert, L. Tcheang, D. Daniels, A. I. Muir, M. J. Wigglesworth, I. Kinghorn, N. J. Fraser, et al. 2003. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. Journal of Biological Chemistry 278 (13):11312–9. doi: 10.1074/jbc.M211609200.
   PubMed Web of Science ®Google Scholar
• Brown, L., J. M. Wolf, R. Prados-Rosales, and A. Casadevall. 2015. Through the wall: Extracellular vesicles in gram-positive bacteria, mycobacteria and fungi. Nature Reviews Microbiology 13 (10):620–30. doi: 10.1038/nrmicro3480.
   PubMed Web of Science ®Google Scholar
• Bueno-Vargas, P., M. Manzano, J. Diaz-Castro, I. López-Aliaga, R. Rueda, and J. M. López-Pedrosa. 2016. Maternal dietary supplementation with oligofructose-enriched inulin in gestating/lactating rats preserves maternal bone and improves bone microarchitecture in their offspring. PLoS One 11 (4):e0154120. doi: 10.1371/journal.pone.0154120.
   PubMed Web of Science ®Google Scholar
• Bunker, J. J., and A. Bendelac. 2018. IgA responses to microbiota. Immunity 49 (2):211–24. doi: 10.1016/j.immuni.2018.08.011.
   PubMed Web of Science ®Google Scholar
• Buzea, C., I. I. Pacheco, and K. Robbie. 2007. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2 (4):MR17–71. doi: 10.1116/1.2815690.
   PubMed Web of Science ®Google Scholar
• Calcinaro, F., S. Dionisi, M. Marinaro, P. Candeloro, V. Bonato, S. Marzotti, R. B. Corneli, E. Ferretti, A. Gulino, F. Grasso, et al. 2005. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48 (8):1565–75. doi: 10.1007/s00125-005-1831-2.
   PubMed Web of Science ®Google Scholar
• Canfora, E. E., C. M. van der Beek, G. D. A. Hermes, G. H. Goossens, J. W. E. Jocken, J. J. Holst, H. M. van Eijk, K. Venema, H. Smidt, E. G. Zoetendal, et al. 2017. Supplementation of diet with galacto-oligosaccharides increases bifidobacteria, but not insulin sensitivity, in obese prediabetic individuals. Gastroenterology 153 (1):87–97.e3. doi: 10.1053/j.gastro.2017.03.051.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., C. Dewever, and N. M. Delzenne. 2004. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. British Journal of Nutrition 92 (3):521–6. doi: 10.1079/BJN20041225.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., C. Knauf, M. A. Iglesias, D. J. Drucker, N. M. Delzenne, and R. Burcelin. 2006. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55 (5):1484–90. doi: 10.2337/db05-1360.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., S. Possemiers, T. Van de Wiele, Y. Guiot, A. Everard, O. Rottier, L. Geurts, D. Naslain, A. Neyrinck, D. M. Lambert, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (8):1091–103. doi: 10.1136/gut.2008.165886.
   PubMed Web of Science ®Google Scholar
• Carding, S., K. Verbeke, D. T. Vipond, B. M. Corfe, and L. J. Owen. 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health & Disease 26:26191. doi: 10.3402/mehd.v26.26191.
   PubMed Web of Science ®Google Scholar
• Carmody, R. N., G. K. Gerber, J. M. Luevano, D. M. Gatti, L. Somes, K. L. Svenson, and P. J. Turnbaugh. 2015. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host and Microbe 17 (1):72–84. doi: 10.1016/j.chom.2014.11.010.
   PubMed Web of Science ®Google Scholar
• Cassani, E., M. Barichella, R. Cancello, F. Cavanna, L. Iorio, E. Cereda, C. Bolliri, P. Z. Maria, F. Bianchi, B. Cestaro, et al. 2015. Increased urinary indoxyl sulfate (indican): New insights into gut dysbiosis in Parkinson’s disease. Parkinsonism & Related Disorders 21 (4):389–93. doi: 10.1016/j.parkreldis.2015.02.004.
   PubMed Web of Science ®Google Scholar
• Catalan-Dibene, J., M. I. Vazquez, V. P. Luu, S.-P. Nuccio, A. Karimzadeh, J. M. Kastenschmidt, S. A. Villalta, I. Ushach, E. J. Pone, P. Casali, et al. 2017. Identification of IL-40, a novel B cell–associated cytokine. The Journal of Immunology 199 (9):3326–35. doi: 10.4049/jimmunol.1700534.
   PubMed Web of Science ®Google Scholar
• Charalampopoulos, D., and R. A. Rastall. 2012. Prebiotics in foods. Current Opinion in Biotechnology 23 (2):187–91. doi: 10.1016/j.copbio.2011.12.028.
   PubMed Web of Science ®Google Scholar
• Chatterjee, S., A. Bandyopadhyay, and K. Sarkar. 2011. Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application. Journal of Nanobiotechnology 9 (1):34. doi: 10.1186/1477-3155-9-34.
   PubMedGoogle Scholar
• Chia, J.-H., T.-S. Wu, T.-L. Wu, C.-L. Chen, C.-H. Chuang, L.-H. Su, H.-J. Chang, C.-C. Lu, A.-J. Kuo, H.-C. Lai, et al. 2018. Clostridium innocuum is a vancomycin-resistant pathogen that may cause antibiotic-associated diarrhoea. Clinical Microbiology and Infection 24 (11):1195–9. doi: 10.1016/j.cmi.2018.02.015.
   PubMed Web of Science ®Google Scholar
• Claus, S. P. 2017. Inulin prebiotic: Is it all about bifidobacteria? Gut 66 (11):1883–4. doi: 10.1136/gutjnl-2017-313800.
   PubMed Web of Science ®Google Scholar
• Cordain, L., S. B. Eaton, A. Sebastian, N. Mann, S. Lindeberg, B. A. Watkins, J. H. O’Keefe, and J. Brand-Miller. 2005. Origins and evolution of the Western diet: Health implications for the 21st century. The American Journal of Clinical Nutrition 81 (2):341–54. doi: 10.1093/ajcn.81.2.341.
   PubMed Web of Science ®Google Scholar
• Costabile, A., I. Buttarazzi, S. Kolida, S. Quercia, J. Baldini, J. R. Swann, P. Brigidi, and G. R. Gibson. 2017. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PLoS One 12 (12):e0187964. doi: 10.1371/journal.pone.0187964.
   PubMed Web of Science ®Google Scholar
• Courtney, C. M., S. M. Goodman, J. A. McDaniel, N. E. Madinger, A. Chatterjee, and P. Nagpal. 2016. Photoexcited quantum dots for killing multidrug-resistant bacteria. Nature Materials 15 (5):529–34. doi: 10.1038/nmat4542.
   PubMed Web of Science ®Google Scholar
• Cullen, T. W., W. B. Schofield, N. A. Barry, E. E. Putnam, E. A. Rundell, M. S. Trent, P. H. Degnan, C. J. Booth, H. Yu, and A. L. Goodman. 2015. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science 347 (6218):170–5. doi: 10.1126/science.1260580.
   PubMed Web of Science ®Google Scholar
• Dahech, I., K. S. Belghith, K. Hamden, A. Feki, H. Belghith, and H. Mejdoub. 2011. Antidiabetic activity of levan polysaccharide in alloxan-induced diabetic rats. International Journal of Biological Macromolecules 49 (4):742–6. doi: 10.1016/j.ijbiomac.2011.07.007.
   PubMed Web of Science ®Google Scholar
• Damman, C. J., S. I. Miller, C. M. Surawicz, and T. L. Zisman. 2012. The microbiome and inflammatory bowel disease: Is there a therapeutic role for fecal microbiota transplantation. American Journal of Gastroenterology 107 (10):1452–9. doi: 10.1038/ajg.2012.93.
   PubMed Web of Science ®Google Scholar
• Dao, M. C., A. Everard, J. Aron-Wisnewsky, N. Sokolovska, E. Prifti, E. O. Verger, B. D. Kayser, F. Levenez, J. Chilloux, L. Hoyles, et al. 2016. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut 65 (3):426–36. doi: 10.1136/gutjnl-2014-308778.
   PubMed Web of Science ®Google Scholar
• Davey, K. J., P. D. Cotter, O. O'Sullivan, F. Crispie, T. G. Dinan, J. F. Cryan, and S. M. O'Mahony. 2013. Antipsychotics and the gut microbiome: Olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Translational Psychiatry 3 (10):e309. doi: 10.1038/tp.2013.83.
   PubMedGoogle Scholar
• Davey, K. J., S. M. O’Mahony, H. Schellekens, O. O’Sullivan, J. Bienenstock, P. D. Cotter, T. G. Dinan, and J. F. Cryan. 2012. Gender-dependent consequences of chronic olanzapine in the rat: Effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 221 (1):155–69. doi: 10.1007/s00213-011-2555-2.
   PubMed Web of Science ®Google Scholar
• David, L. A., C. F. Maurice, R. N. Carmody, D. B. Gootenberg, J. E. Button, B. E. Wolfe, A. V. Ling, A. S. Devlin, Y. Varma, M. A. Fischbach, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (7484):559–63. doi: 10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• de la Cuesta-Zuluaga, J., V. Corrales-Agudelo, E. P. Velásquez-Mejía, J. A. Carmona, J. M. Abad, and J. S. Escobar. 2018. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of westernization. Scientific Reports 8 (1):11356. doi: 10.1038/s41598-018-29687-x.
   PubMedGoogle Scholar
• Delgado, G. T. C., W. M. S. C. Tamashiro, and G. M. Pastore. 2010. Immunomodulatory effects of fructans. Food Research International 43 (5):1231–6. doi: 10.1016/j.foodres.2010.04.023.
   Web of Science ®Google Scholar
• den Besten, G., K. van Eunen, A. K. Groen, K. Venema, D.-J. Reijngoud, and B. M. Bakker. 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54 (9):2325–40. doi: 10.1194/jlr.R036012.
   PubMed Web of Science ®Google Scholar
• De Paepe, M., M. Leclerc, C. R. Tinsley, and M.-A. Petit. 2014. Bacteriophages: An underestimated role in human and animal health? Frontiers in Cellular and Infection Microbiology 4:39. doi: 10.3389/fcimb.2014.00039.
   PubMed Web of Science ®Google Scholar
• Depommier, C., A. Everard, C. Druart, H. Plovier, M. Van Hul, S. Vieira-Silva, G. Falony, J. Raes, D. Maiter, N. M. Delzenne, et al. 2019. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nature Medicine 25 (7):1096–103. doi: 10.1038/s41591-019-0495-2.
   PubMed Web of Science ®Google Scholar
• Derrien, M., M. C. Collado, K. Ben-Amor, S. Salminen, and W. M. De Vos. 2008. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and Environmental Microbiology 74 (5):1646–8. doi: 10.1128/AEM.01226-07.
   PubMed Web of Science ®Google Scholar
• Di Cerbo, A., B. Palmieri, M. Aponte, J. C. Morales-Medina, and T. Iannitti. 2016. Mechanisms and therapeutic effectiveness of Lactobacilli. Journal of Clinical Pathology 69 (3):187–203. doi: 10.1136/jclinpath-2015-202976.
   PubMed Web of Science ®Google Scholar
• Didari, T., S. Solki, S. Mozaffari, S. Nikfar, and M. Abdollahi. 2014. A systematic review of the safety of probiotics. Expert Opinion on Drug Safety 13 (2):227–39. doi: 10.1517/14740338.2014.872627.
   PubMed Web of Science ®Google Scholar
• Didesch, M. M., A. Averill, and M. Oh-Park. 2016. Peripheral neuropathy after fecal microbiota transplantation for Clostridium difficile infection: A case report. PM and R 8 (8):813–6. doi: 10.1016/j.pmrj.2016.01.009.
   PubMedGoogle Scholar
• Donaldson, G. P., S. M. Lee, and S. K. Mazmanian. 2015. Gut biogeography of the bacterial microbiota. Nature Reviews Microbiology 14 (1):20–32. doi: 10.1038/nrmicro3552.
   PubMed Web of Science ®Google Scholar
• Douglas, L. C., and M. E. Sanders. 2008. Probiotics and prebiotics in dietetics practice. Journal of the American Dietetic Association 108 (3):510–21. doi: 10.1016/j.jada.2007.12.009.
   PubMed Web of Science ®Google Scholar
• Duerkop, B. A., C. V. Clements, D. Rollins, J. L. M. Rodrigues, and L. V. Hooper. 2012. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proceedings of the National Academy of Sciences 109 (43):17621–6. doi: 10.1073/pnas.1206136109.
   PubMed Web of Science ®Google Scholar
• Dykes, G. M. 2001. Dendrimers: A review of their appeal and applications. Journal of Chemical Technology and Biotechnology 38 (2):311–24. doi: 10.1002/jctb.464.
   Google Scholar
• Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson, and D. A. Relman. 2005. Diversity of the human intestinal microbial flora. Science (New York, N.Y.) 308 (5728):1635–8. doi: 10.1126/science.1110591.
   PubMed Web of Science ®Google Scholar
• Eiseman, B., W. Silen, G. S. Bascom, and A. J. Kauvar. 1958. Fecal enema as an adjunct in the treatment of Pseudomembranous enterocolitis. Surgery 44 (5):854–9. doi: 10.1067/S0039-6060(03)00474-4.
   PubMed Web of Science ®Google Scholar
• Ejtahed, H. S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, V. Mofid, and A. Akbarian-Moghari. 2011. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. Journal of Dairy Science 94 (7):3288–94. doi: 10.3168/jds.2010-4128.
   PubMed Web of Science ®Google Scholar
• El-Soud, N. H. A., R. N. Said, D. S. Mosallam, N. A. M. Barakat, and M. A. Sabry. 2015. Bifidobacterium lactis in treatment of children with acute diarrhea. A randomized double blind controlled trial. Open Access Macedonian Journal of Medical Sciences 3 (3):403–7. doi: 10.3889/oamjms.2015.088.
   PubMedGoogle Scholar
• Elison, E., L. K. Vigsnaes, L. Rindom Krogsgaard, J. Rasmussen, N. Sorensen, B. McConnell, T. Hennet, M. O. A. Sommer, and P. Bytzer. 2016. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. British Journal of Nutrition 116 (8):1356–68. doi: 10.1017/S0007114516003354.
   PubMed Web of Science ®Google Scholar
• Elizaquível, P., G. Sánchez, A. Salvador, S. Fiszman, M. T. Dueñas, P. López, P. Fernández de Palencia, and R. Aznar. 2011. Evaluation of yogurt and various beverages as carriers of lactic acid bacteria producing 2-branched (1,3)-β-d-glucan. Journal of Dairy Science 94 (7):3271–8. doi: 10.3168/jds.2010-4026.
   PubMed Web of Science ®Google Scholar
• Eloe-Fadrosh, E. A., M. A. McArthur, A. M. Seekatz, E. F. Drabek, D. A. Rasko, M. B. Sztein, and C. M. Fraser. 2013. Impact of oral typhoid vaccination on the human gut microbiota and correlations with S. typhi-specific immunological responses. PLoS One 8 (4):e62026. doi: 10.1371/journal.pone.0062026.
   PubMed Web of Science ®Google Scholar
• Eswaran, S., J. Muir, and W. D. Chey. 2013. Fiber and functional gastrointestinal disorders. American Journal of Gastroenterology 108 (5):718–27. doi: 10.1038/ajg.2013.63.
   PubMed Web of Science ®Google Scholar
• Everard, A., C. Belzer, L. Geurts, J. P. Ouwerkerk, C. Druart, L. B. Bindels, Y. Guiot, M. Derrien, G. G. Muccioli, N. M. Delzenne, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences 110 (22):9066–71. doi: 10.1073/pnas.1219451110.
   PubMed Web of Science ®Google Scholar
• Eyking, A., H. Reis, M. Frank, G. Gerken, K. W. Schmid, E. Cario, B. W. Stewart, C. Wild, F. Bosman, F. Carneiro, et al. 2016. MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer. PLoS One 11 (6):e0156871. doi: 10.1371/journal.pone.0156871.
   PubMed Web of Science ®Google Scholar
• Falony, G., M. Joossens, S. Vieira-Silva, J. Wang, Y. Darzi, K. Faust, A. Kurilshikov, M. J. Bonder, M. Valles-Colomer, D. Vandeputte, et al. 2016. Population-level analysis of gut microbiome variation. Science 352 (6285):560–4. doi: 10.1126/science.aad3503.
   PubMed Web of Science ®Google Scholar
• FAO and WHO. 2002. Guidelines for the Evaluation of Probiotics in Food. doi: 10.1111/j.1469-0691.2012.03873.
   Google Scholar
• Fattal, E., J. Rojas, M. Youssef, P. Couvreur, and A. Andremont. 1991. Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrobial Agents and Chemotherapy 35 (4):770–2. doi: 10.1128/AAC.35.4.770.
   PubMed Web of Science ®Google Scholar
• Fitzstevens, J. L., K. C. Smith, J. I. Hagadorn, M. J. Caimano, A. P. Matson, and E. A. Brownell. 2017. Systematic review of the human milk microbiota. Nutrition in Clinical Practice 32 (3):354–64. doi: 10.1177/0884533616670150.
   PubMed Web of Science ®Google Scholar
• Flowers, S. A., S. J. Evans, K. M. Ward, M. G. McInnis, and V. L. Ellingrod. 2017. Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (3):261–7. doi: 10.1002/phar.1890.
   Google Scholar
• Fodor, J. G., E. Helis, N. Yazdekhasti, and B. Vohnout. 2014. ‘Fishing’ for the origins of the ‘Eskimos and heart disease’ story: Facts or wishful thinking? Canadian Journal of Cardiology 30 (8):864–8. doi: 10.1016/j.cjca.2014.04.007.
   PubMed Web of Science ®Google Scholar
• Fondevila, M., R. Herrer, M. C. Casallas, L. Abecia, and J. J. Ducha. 2009. Silver nanoparticles as a potential antimicrobial additive for weaned pigs. Animal Feed Science and Technology 150 (3–4):259–69. doi: 10.1016/j.anifeedsci.2008.09.003.
   Web of Science ®Google Scholar
• Forslund, K., F. Hildebrand, T. Nielsen, G. Falony, E. Le Chatelier, S. Sunagawa, E. Prifti, S. Vieira-Silva, V. Gudmundsdottir, H. Krogh Pedersen, et al. 2015. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (7581):262–6. doi: 10.1038/nature15766.
   PubMed Web of Science ®Google Scholar
• Frank, D. N., A. L. St Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America 104 (34):13780–5. doi: 10.1073/pnas.0706625104.
   PubMed Web of Science ®Google Scholar
• Fröhlich, E. E., and E. Fröhlich. 2016. Cytotoxicity of nanoparticles contained in food on intestinal cells and the gut microbiota. International Journal of Molecular Sciences 17 (4):509. doi: 10.3390/ijms17040509.
   PubMed Web of Science ®Google Scholar
• Fujiya, M., M. W. Musch, Y. Nakagawa, S. Hu, J. Alverdy, Y. Kohgo, O. Schneewind, B. Jabri, and E. B. Chang. 2007. The bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host & Microbe 1 (4):299–308. doi: 10.1016/j.chom.2007.05.004.
   PubMed Web of Science ®Google Scholar
• Furet, J.-P., L.-C. Kong, J. Tap, C. Poitou, A. Basdevant, J.-L. Bouillot, D. Mariat, G. Corthier, J. Dore, C. Henegar, et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 59 (12):3049–57. doi: 10.2337/db10-0253.
   PubMed Web of Science ®Google Scholar
• Furrie, E., S. Macfarlane, A. Kennedy, J. H. Cummings, S. V. Walsh, D. A. O’Neil, and G. T. Macfarlane. 2005. Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 54 (2):242–9. doi: 10.1136/gut.2004.044834.
   PubMed Web of Science ®Google Scholar
• Garner, C. D., D. A. Antonopoulos, B. Wagner, G. E. Duhamel, I. Keresztes, D. A. Ross, V. B. Young, and C. Altier. 2009. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infection and Immunity 77 (7):2691–702. doi: 10.1128/IAI.01570-08.
   PubMed Web of Science ®Google Scholar
• Geirnaert, A., M. Calatayud, C. Grootaert, D. Laukens, S. Devriese, G. Smagghe, M. De Vos, N. Boon, and T. Van de Wiele. 2017. Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Scientific Reports 7 (1):11450. doi: 10.1038/s41598-017-11734-8.
   PubMedGoogle Scholar
• Gibson, G. R., R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, K. Scott, C. Stanton, K. S. Swanson, P. D. Cani, et al. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology 14:491. doi: 10.1038/nrgastro.2017.75.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R., H. M. Probert, J. V. Loo, R. A. Rastall, and M. B. Roberfroid. 2004. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 17 (2):259–75. doi: 10.1079/NRR200479.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R., and M. B. Roberfroid. 1995. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 125 (6):1401–12. doi: 10.1079/NRR200479.
   PubMed Web of Science ®Google Scholar
• Giraffa, G., N. Chanishvili, and Y. Widyastuti. 2010. Importance of Lactobacilli in food and feed biotechnology. Research in Microbiology 161 (6):480–7. doi: 10.1016/j.resmic.2010.03.001.
   PubMed Web of Science ®Google Scholar
• González-Campos, J. B., J. D. Mota-Morales, S. Kumar, D. Zárate-Triviño, M. Hernández-Iturriaga, Y. Prokhorov, M. V. Lepe, Z. Y. García-Carvajal, I. C. Sanchez, and G. Luna-Bárcenas. 2013. New insights into the bactericidal activity of chitosan-Ag bionanocomposite: The role of the electrical conductivity. Colloids and Surfaces B: Biointerfaces 111:741–6. doi: 10.1016/j.colsurfb.2013.07.003.
   PubMed Web of Science ®Google Scholar
• Goodrich, J. K., J. L. Waters, A. C. Poole, J. L. Sutter, O. Koren, R. Blekhman, M. Beaumont, W. Van Treuren, R. Knight, J. T. Bell, et al. 2014. Human genetics shape the gut microbiome. Cell 159 (4):789–99. doi: 10.1016/j.cell.2014.09.053.
   PubMed Web of Science ®Google Scholar
• Govender, M., Y. E. Choonara, P. Kumar, L. C. Du Toit, S. van Vuuren, and V. Pillay. 2014. A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech 15 (1):29–43. doi: 10.1208/s12249-013-0027-1.
   PubMed Web of Science ®Google Scholar
• Graf, D., R. Di Cagno, F. Fåk, H. J. Flint, M. Nyman, M. Saarela, and B. Watzl. 2015. Contribution of diet to the composition of the human gut microbiota. Microbial Ecology in Health & Disease 26:26164. doi: 10.3402/mehd.v26.26164.
   PubMed Web of Science ®Google Scholar
• Guirguis-Blake, J. M., C. V. Evans, C. A. Senger, E. A. O'Connor, and E. P. Whitlock. 2016. Aspirin for the primary prevention of cardiovascular events: A systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 164 (12):804. doi: 10.7326/M15-2113.
   PubMed Web of Science ®Google Scholar
• Gurunathan, S., J. W. Han, D. Nam Kwon, and J. H. Kim. 2014. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against gram-negative and gram-positive bacteria. Nanoscale Research Letters 9 (1):373. doi: 10.1186/1556-276X-9-373.
   PubMedGoogle Scholar
• Hamilton-Miller, J. M. T., G. R. Gibson, and W. Bruck. 2003. Some insights into the derivation and early uses of the word ‘probiotic’. British Journal of Nutrition 90 (4):845. doi: 10.1079/BJN2003954.
   PubMed Web of Science ®Google Scholar
• Han, Y. W. 1990. Microbial levan. Advances in Applied Microbiology 35:171–94. doi: 10.1016/S0065-2164(08)70244-2.
   PubMedGoogle Scholar
• Harmsen, H. J. M., A. C. M. Wildeboer-Veloo, G. C. Raangs, A. A. Wagendorp, N. Klijn, J. G. Bindels, and G. W. Welling. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition 30 (1):61–7. doi: 10.1097/00005176-200001000-00019.
   PubMed Web of Science ®Google Scholar
• Hayes, C. L., J. Dong, H. J. Galipeau, J. Jury, J. McCarville, X. Huang, X.-Y. Wang, A. Naidoo, A. N. Anbazhagan, J. Libertucci, et al. 2018. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Scientific Reports 8 (1):14184. doi: 10.1038/s41598-018-32366-6.
   PubMedGoogle Scholar
• Health Canada. 2009. Accepted claims about the nature of probiotic microorganisms in food. In CFIA Guide to Food Labelling and Advertising (Guide). Ottawa: Health Canada.
   Google Scholar
• Henry, B. D., D. R. Neill, K. A. Becker, S. Gore, L. Bricio-Moreno, R. Ziobro, M. J. Edwards, K. Mühlemann, J. Steinmann, B. Kleuser, et al. 2015. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nature Biotechnology 33 (1):81–8. doi: 10.1038/nbt.3037.
   PubMed Web of Science ®Google Scholar
• Hernández-Moedano, A., E. F., Moreno-Ramos, S. E. Herrera-Rodríguez, and M. González-Ávila. 2014. Changes in intestinal microorganisms influenced by agave fructansinA digestive tract simulator. Journal of Chemical, Biological and Physical Sciences 4 (5):19–25.
   Google Scholar
• Herrera, M., S. Salva, J. Villena, N. Barbieri, G. Marranzino, and S. Alvarez. 2014. Dietary supplementation with Lactobacilli improves emergency granulopoiesis in protein-malnourished mice and enhances respiratory innate immune response. PLoS One 9 (4):e90227. doi: 10.1371/journal.pone.0090227.
   PubMed Web of Science ®Google Scholar
• Hibberd, A. A., A. Lyra, A. C. Ouwehand, P. Rolny, H. Lindegren, L. Cedgård, and Y. Wettergren. 2017. Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterology 4 (1):e000145. doi: 10.1136/bmjgast-2017-000145.
   PubMed Web of Science ®Google Scholar
• Hirai, M., T. Azuma, S. Ito, T. Kato, and Y. Kohli. 1995. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori. Journal of Gastroenterology 30 (4):461–4. doi: 10.1007/BF02347561.
   PubMed Web of Science ®Google Scholar
• Hoban, A. E., R. M. Stilling, F. J. Ryan, F. Shanahan, T. G. Dinan, M. J. Claesson, G. Clarke, and J. F. Cryan. 2016. Regulation of prefrontal cortex myelination by the microbiota. Translational Psychiatry 6 (4):e774. doi: 10.1038/tp.2016.42.
   PubMedGoogle Scholar
• Honda, K., and D. R. Littman. 2016. The microbiota in adaptive immune homeostasis and disease. Nature 535 (7610):75–84. doi: 10.1038/nature18848.
   PubMed Web of Science ®Google Scholar
• Hoskins, J., W. E. Alborn, J. Arnold, L. C. Blaszczak, S. Burgett, B. S. DeHoff, S. T. Estrem, L. Fritz, D.-J. Fu, W. Fuller, et al. 2001. Genome of the bacterium Streptococcus pneumoniae strain R6. Journal of Bacteriology 183 (19):5709–17. doi: 10.1128/JB.183.19.5709-5717.2001.
   PubMed Web of Science ®Google Scholar
• Hsieh, Y. H. P., and J. A. Ofori. 2007. Innovations in food technology for health. Asia Pacific Journal of Clinical Nutrition 16 (Suppl 1):65–73.
   PubMed Web of Science ®Google Scholar
• Hua, S., M. B. C. de Matos, J. M. Metselaar, and G. Storm. 2018. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: Pathways for translational development and commercialization. Frontiers in Pharmacology 9:790. doi: 10.3389/fphar.2018.00790.
   PubMed Web of Science ®Google Scholar
• Hua, X., J. J. Goedert, A. Pu, G. Yu, and J. Shi. 2016. Allergy associations with the adult fecal microbiota: Analysis of the American Gut Project. EBioMedicine 3:172–79. doi: 10.1016/j.ebiom.2015.11.038.
   PubMed Web of Science ®Google Scholar
• Hume, M. E. 2011. Historic perspective: Prebiotics, probiotics, and other alternatives to antibiotics. Poultry Science 90 (11):2663–9. doi: 10.3382/ps.2010-01030.
   PubMed Web of Science ®Google Scholar
• Inoue, Y., T. Kambara, N. Murata, J. Komori-Yamaguchi, S. Matsukura, Y. Takahashi, Z. Ikezawa, and M. Aihara. 2014. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: A double-blind, randomized, clinical trial. International Archives of Allergy and Immunology 165 (4):247–54. doi: 10.1159/000369806.
   PubMed Web of Science ®Google Scholar
• Iwahi, T., H. Satoh, M. Nakao, T. Iwasaki, T. Yamazaki, K. Kubo, T. Tamura, and A. Imada. 1991. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrobial Agents and Chemotherapy 35 (3):490–96. doi: 10.1128/AAC.35.3.490.
   PubMed Web of Science ®Google Scholar
• Jackson, M. A., J. K. Goodrich, M.-E. Maxan, D. E. Freedberg, J. A. Abrams, A. C. Poole, J. L. Sutter, D. Welter, R. E. Ley, J. T. Bell, et al. 2016. Proton pump inhibitors alter the composition of the gut microbiota. Gut 65 (5):749–56. doi: 10.1136/gutjnl-2015-310861.
   PubMed Web of Science ®Google Scholar
• Jaskiewicz, J., Y. Zhao, J. W. Hawes, Y. Shimomura, D. W. Crabb, and R. A. Harris. 1996. Catabolism of isobutyrate by colonocytes. Archives of Biochemistry and Biophysics 327 (2):265–70. doi: 10.1006/abbi.1996.0120.
   PubMed Web of Science ®Google Scholar
• Jiang, F., D. Meng, M. Weng, W. Zhu, W. Wu, D. Kasper, and W. A. Walker. 2017. The symbiotic bacterial surface factor polysaccharide A on bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4. PLoS One 12 (3):e0172738. doi: 10.1371/journal.pone.0172738.
   PubMed Web of Science ®Google Scholar
• Jost, T., C. Lacroix, C. P. Braegger, and C. Chassard. 2012. New insights in gut microbiota establishment in healthy breast fed neonates. PLoS One 7 (8):e44595. doi: 10.1371/journal.pone.0044595.
   PubMed Web of Science ®Google Scholar
• Jung, T. H., W. M. Jeon, and K. S. Han. 2015. In vitro effects of dietary inulin on human fecal microbiota and butyrate production. Journal of Microbiology and Biotechnology 25 (9):1555–8. doi: 10.4014/jmb.1505.05078.
   PubMed Web of Science ®Google Scholar
• Kalliomäki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 357 (9262):1076–9. doi: 10.1016/S0140-6736(00)04259-8.
   PubMed Web of Science ®Google Scholar
• Kamo, T., H. Akazawa, W. Suda, A. Saga-Kamo, Y. Shimizu, H. Yagi, Q. Liu, S. Nomura, A. T. Naito, N. Takeda, et al. 2017. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS One 12 (3):e0174099. doi: 10.1371/journal.pone.0174099.
   PubMed Web of Science ®Google Scholar
• Kao, D., B. Roach, M. Silva, P. Beck, K. Rioux, G. G. Kaplan, H.-J. Chang, S. Coward, K. J. Goodman, H. Xu, et al. 2017. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: A randomized clinical trial. JAMA - Journal of the American Medical Association 318 (20):1985. doi: 10.1001/jama.2017.17077.
   PubMed Web of Science ®Google Scholar
• Kellow, N. J., M. T. Coughlan, and C. M. Reid. 2014. Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials. British Journal of Nutrition 111 (7):1147–61. doi: 10.1017/S0007114513003607.
   PubMed Web of Science ®Google Scholar
• Kelly, C. P. 2013. Fecal microbiota transplantation—An old therapy comes of age. New England Journal of Medicine 368 (5):474–5. doi: 10.1056/NEJMe1214816.
   PubMed Web of Science ®Google Scholar
• Kim, J. Y., J. H. Kwon, S. H. Ahn, S. I. Lee, Y. S. Han, Y. O. Choi, S. Y. Lee, K. M. Ahn, and G. E. Ji. 2010. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatric Allergy and Immunology 21 (2p2):e386–93. doi: 10.1111/j.1399-3038.2009.00958.x.
   PubMedGoogle Scholar
• Kim, M., Y. Qie, J. Park, and C. H. Kim. 2016. Gut microbial metabolites fuel host antibody responses. Cell Host and Microbe 20 (2):202–14. doi: 10.1016/j.chom.2016.07.001.
   PubMed Web of Science ®Google Scholar
• Kim, M. H., S. G. Kang, J. H. Park, M. Yanagisawa, and C. H. Kim. 2013. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145 (2):396–406. doi: 10.1053/j.gastro.2013.04.056.
   PubMed Web of Science ®Google Scholar
• Kleerebezem, M., and E. E. Vaughan. 2009. Probiotic and gut lactobacilli and bifidobacteria: Molecular approaches to study diversity and activity. Annual Review of Microbiology 63 (1):269–90. doi: 10.1146/annurev.micro.091208.073341.
   PubMedGoogle Scholar
• Kobyliak, N., C. Conte, G. Cammarota, A. P. Haley, I. Styriak, L. Gaspar, J. Fusek, L. Rodrigo, and P. Kruzliak. 2016. Probiotics in prevention and treatment of obesity: A critical view. Nutrition and Metabolism 13:14. doi: 10.1186/s12986-016-0067-0.
   Google Scholar
• Kolida, S., K. Tuohy, and G. R. Gibson. 2002. Prebiotic effects of inulin and oligofructose. British Journal of Nutrition 87 (S2):S193–S7. doi: 10.1079/BJN/2002537.
   PubMedGoogle Scholar
• Kong, G., K.-A L. Cao, L. M. Judd, S. Li, T. Renoir, and A. J. Hannan. 2018. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington’s disease. Neurobiology of Disease 2018:104268. doi: 10.1016/j.nbd.2018.09.001.
   Google Scholar
• Kortright, K. E., B. K. Chan, J. L. Koff, and P. E. Turner. 2019. Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host and Microbe 25 (2):219–32. doi: 10.1016/j.chom.2019.01.014.
   PubMed Web of Science ®Google Scholar
• Kostic, A. D., D. Gevers, H. Siljander, T. Vatanen, T. Hyötyläinen, A.-M. Hämäläinen, A. Peet, V. Tillmann, P. Pöhö, I. Mattila, et al. 2015. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host & Microbe 17 (2):260–73. doi: 10.1016/j.chom.2015.01.001.
   PubMed Web of Science ®Google Scholar
• Kumar, H., S. Salminen, H. Verhagen, I. Rowland, J. Heimbach, S. Bañares, T. Young, K. Nomoto, and M. Lalonde. 2015. Novel probiotics and prebiotics: Road to the market. Current Opinion in Biotechnology 32:99–103. doi: 10.1016/j.copbio.2014.11.021.
   PubMed Web of Science ®Google Scholar
• Lam, V., J. Su, S. Koprowski, A. Hsu, J. S. Tweddell, P. Rafiee, G. J. Gross, N. H. Salzman, and J. E. Baker. 2012. Intestinal microbiota determine severity of myocardial infarction in rats. The FASEB Journal 26 (4):1727–35. doi: 10.1096/fj.11-197921.
   PubMed Web of Science ®Google Scholar
• Lazar, V., L. M. Ditu, G. Gradisteanu Pircalabioru, I. Gheorghe, C. Curutiu, A. M. Holban, A. Picu, L. Petcu, and M. C. Chifiriuc. 2018. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Frontiers in Immunology 9:1830. doi: 10.3389/fimmu.2018.01830.
   PubMed Web of Science ®Google Scholar
• Le, C. F., C. M. Fang, and S. D. Sekaran. 2017. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrobial Agents and Chemotherapy 61 (4):e02340-16. doi: 10.1128/AAC.02340-16.
   PubMed Web of Science ®Google Scholar
• Lee, M. B., and J. D. Greig. 2012. A review of nosocomial Salmonella outbreaks: Infection control interventions found effective. Public Health 127 (3):199–206. doi: 10.1016/j.puhe.2012.12.013.
   Web of Science ®Google Scholar
• Levinson, K. J., M. De Jesus, and N. J. Mantis. 2015. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology. Infection and Immunity 83 (4):1674–83. doi: 10.1128/IAI.02856-14.
   PubMed Web of Science ®Google Scholar
• Levy, M., A. A. Kolodziejczyk, C. A. Thaiss, and E. Elinav. 2017. Dysbiosis and the immune system. Nature Reviews Immunology 17 (4):219–32. doi: 10.1038/nri.2017.7.
   PubMed Web of Science ®Google Scholar
• Lewin, R. A. 2001. More on merde. Perspectives in Biology and Medicine 44 (4):594–607. doi: 10.1353/pbm.2001.0067.
   PubMed Web of Science ®Google Scholar
• Li, B., C. Selmi, R. Tang, M. E. Gershwin, and X. Ma. 2018. The microbiome and autoimmunity: A paradigm from the gut–liver axis. Cellular & Molecular Immunology 15 (6):595–609. doi: 10.1038/cmi.2018.7.
   PubMed Web of Science ®Google Scholar
• Li, J., S. Lin, P. M. Vanhoutte, C. W. Woo, and A. Xu. 2016. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe−/− mice. Circulation 133 (24):2434–46. doi: 10.1161/CIRCULATIONAHA.115.019645.
   PubMed Web of Science ®Google Scholar
• Li, X., S. M. Robinson, A. Gupta, K. Saha, Z. Jiang, D. F. Moyano, A. Sahar, M. A. Riley, and V. M. Rotello. 2014. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano 8 (10):10682–6. doi: 10.1021/nn5042625.
   PubMed Web of Science ®Google Scholar
• Li, Z., C.-X. Yi, S. Katiraei, S. Kooijman, E. Zhou, C. K. Chung, Y. Gao, J. K. van den Heuvel, O. C. Meijer, J. F. P. Berbée, et al. 2018. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut 67 (7):1269–79. doi: 10.1136/gutjnl-2017-314050.
   PubMed Web of Science ®Google Scholar
• Liévin-Le Moal, V., and A. L. Servin. 2014. Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: From probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clinical Microbiology Reviews 27 (2):167–99. doi: 10.1128/CMR.00080-13.
   PubMed Web of Science ®Google Scholar
• Lilly, D. M., and R. H. Stillwell. 1965. Probiotics: Growth-promoting factors produced by microorganisms. Science 147 (3659):747–8. doi: 10.1126/science.147.3659.747.
   PubMed Web of Science ®Google Scholar
• Liu, F., M. Prabhakar, J. Ju, H. Long, and H. W. Zhou. 2017. Effect of inulin-type fructans on blood lipid profile and glucose level: A systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition 71 (1):9–20. doi: 10.1038/ejcn.2016.156.
   PubMed Web of Science ®Google Scholar
• Lodinová-Zádníková, R., B. Cukrowska, and H. Tlaskalova-Hogenova. 2003. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). International Archives of Allergy and Immunology 131 (3):209–11. doi: 10.1159/000071488.
   PubMed Web of Science ®Google Scholar
• Lopetuso, L. R., F. Scaldaferri, F. Franceschi, and A. Gasbarrini. 2016. Bacillus clausii and gut homeostasis: State of the art and future perspectives. Expert Review of Gastroenterology & Hepatology 10 (8):943–48. doi: 10.1080/17474124.2016.1200465.
   PubMed Web of Science ®Google Scholar
• Lozupone, C. A., J. I. Stombaugh, J. I. Gordon, J. K. Jansson, and R. Knight. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489 (7415):220–30. doi: 10.1038/nature11550.
   PubMed Web of Science ®Google Scholar
• Łusiak-Szelachowska, M., B. Weber-Dąbrowska, E. Jończyk-Matysiak, R. Wojciechowska, and A. Górski. 2017. Bacteriophages in the gastrointestinal tract and their implications. Gut Pathogens 9 (1):44. doi: 10.1186/s13099-017-0196-7.
   PubMedGoogle Scholar
• Machiels, K., M. Joossens, J. Sabino, V. De Preter, I. Arijs, V. Eeckhaut, V. Ballet, K. Claes, F. Van Immersel, K. Verbeke, et al. 2014. A Decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63 (8):1275–83. doi: 10.1136/gutjnl-2013-304833.
   PubMed Web of Science ®Google Scholar
• Maier, L., M. Pruteanu, M. Kuhn, G. Zeller, A. Telzerow, E. E. Anderson, A. R. Brochado, K. C. Fernandez, H. Dose, H. Mori, et al. 2018. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555 (7698):623–8. doi: 10.1038/nature25979.
   PubMed Web of Science ®Google Scholar
• Mancilla-Margalli, N. A., and M. G. Lopez. 2006. Water-soluble carbohydrates and fructan structure patterns from Agave and Dasylirion species. Journal of Agricultural and Food Chemistry 54 (20):7832–9. doi: 10.1021/jf060354v.
   PubMed Web of Science ®Google Scholar
• Manfredo Vieira, S., M. Hiltensperger, V. Kumar, D. Zegarra-Ruiz, C. Dehner, N. Khan, F. R. C. Costa, E. Tiniakou, T. Greiling, W. Ruff, et al. 2018. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359 (6380):1156–61. doi: 10.1126/science.aar7201.
   PubMed Web of Science ®Google Scholar
• Manrique, P., B. Bolduc, S. T. Walk, J. Van Der Oost, W. M. De Vos, and M. J. Young. 2016. Healthy human gut phageome. Proceedings of the National Academy of Sciences 113 (37):10400–5. doi: 10.1073/pnas.1601060113.
   PubMed Web of Science ®Google Scholar
• Markovits, N., R. Loebstein, H. Halkin, M. Bialik, J. Landes-Westerman, J. Lomnicky, and D. Kurnik. 2014. The association of proton pump inhibitors and hypomagnesemia in the community setting. The Journal of Clinical Pharmacology 54 (8):889–95. doi: 10.1002/jcph.316.
   PubMed Web of Science ®Google Scholar
• Márquez-Aguirre, A. L., R. M. Camacho-Ruiz, M. Arriaga-Alba, E. Padilla-Camberos, M. Reinhart Kirchmayr, J. L. Blasco, and M. González-Avila. 2013. Effects of Agave tequilana fructans with different degree of polymerization profiles on the body weight, blood lipids and count of fecal Lactobacilli/Bifidobacteria in obese mice. Food and Function 4 (8):1237–44. doi: 10.1039/c3fo60083a.
   PubMed Web of Science ®Google Scholar
• Martín, R., S. Miquel, L. Benevides, C. Bridonneau, V. Robert, S. Hudault, F. Chain, O. Berteau, V. Azevedo, J. M. Chatel, et al. 2017. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. prausnitzii as a next-generation probiotic. Frontiers in Microbiology 8:1226. doi: 10.3389/fmicb.2017.01226.
   PubMed Web of Science ®Google Scholar
• Mathipa, M., and M. Thantsha. 2015. Cocktails of probiotics pre-adapted to multiple stress factors are more robust under simulated gastrointestinal conditions than their parental counterparts and exhibit enhanced antagonistic capabilities against Escherichia coli and Staphylococcus aureus. Gut Pathogens 7 (1):5. doi: 10.1186/s13099-015-0053-5.
   PubMedGoogle Scholar
• Matijašić, B. B., T. Obermajer, L. Lipoglavšek, I. Grabnar, G. Avguštin, and I. Rogelj. 2014. Association of dietary type with fecal microbiota in vegetarians and omnivores in Slovenia. European Journal of Nutrition 53 (4):1051–64. doi: 10.1007/s00394-013-0607-6.
   PubMed Web of Science ®Google Scholar
• Matsuhira, H., K. Ichi Tamura, H. Tamagake, Y. Sato, H. Anzai, and M. Yoshida. 2014. High production of plant type levan in sugar beet transformed with timothy (Phleum pratense) 6-SFT genes. Journal of Biotechnology 192:215–22. doi: 10.1016/j.jbiotec.2014.09.025.
   PubMed Web of Science ®Google Scholar
• McCafferty, K., C. Byrne, and M. Yaqoob. 2012. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB Journal 26 (11):4388. doi: 10.1096/fj.12-1102LTR.
   PubMed Web of Science ®Google Scholar
• Metchnikoff, É. 1903. The nature of man: Studies in optimistic philosophy, ed. P. Chalmers Mitchell, 61–77, 251–56. New York and London: G.P. Putnam’s Sons.
   Google Scholar
• Metchnikoff, E. 1908. Prolongation of life, optimistic studies. New York and London: Putman’s Sons.
   Google Scholar
• Mills, S., F. Shanahan, C. Stanton, C. Hill, A. Coffey, and R. P. Ross. 2013. Movers and shakers: Influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4 (1):4–16. doi: 10.4161/gutm.22371.
   PubMed Web of Science ®Google Scholar
• Moreno-Vilet, L., M. H. Garcia-Hernandez, R. E. Delgado-Portales, N. E. Corral-Fernandez, N. Cortez-Espinosa, M. A. Ruiz-Cabrera, and D. P. Portales-Perez. 2014. In vitro assessment of Agave fructans (Agave salmiana) as prebiotics and immune system activators. International Journal of Biological Macromolecules 63:181–7. doi: 10.1016/j.ijbiomac.2013.10.039.
   PubMed Web of Science ®Google Scholar
• Moro, G., S. Arslanoglu, B. Stahl, J. Jelinek, U. Wahn, and G. Boehm. 2006. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Archives of Disease in Childhood 91 (10):814–9. doi: 10.1136/adc.2006.098251.
   PubMed Web of Science ®Google Scholar
• Morrison, D. J., and T. Preston. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (3):189–200. doi: 10.1080/19490976.2015.1134082.
   PubMed Web of Science ®Google Scholar
• Moya, A., and M. Ferrer. 2016. Functional redundancy-induced stability of gut microbiota subjected to disturbance. Trends in Microbiology 24 (5):402–13. doi: 10.1016/j.tim.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Moya, A., J. Peretó, R. Gil, and A. Latorre. 2008. Learning how to live together: Genomic insights into prokaryote-animal symbioses. Nature Reviews Genetics 9 (3):218–29. doi: 10.1038/nrg2319.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., T. Hao, E. B. Rimm, W. C. Willett, and F. B. Hu. 2011. Changes in diet and lifestyle and long-term weight gain in women and men. New England Journal of Medicine 364 (25):2392–404. doi: 10.1056/NEJMoa1014296.
   PubMed Web of Science ®Google Scholar
• Näse, L., K. Hatakka, E. Savilahti, M. Saxelin, A. Pönkä, T. Poussa, R. Korpela, and J. H. Meurman. 2001. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Research 35 (6):412–20. doi: 10.1159/000047484.
   PubMed Web of Science ®Google Scholar
• Nicolas, S., V. Blasco‐Baque, A. Fournel, J. Gilleron, P. Klopp, A. Waget, F. Ceppo, A. Marlin, R. Padmanabhan, J. S. Iacovoni, et al. 2017. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Molecular Systems Biology 13 (3):921. doi: 10.15252/msb.20167356.
   PubMed Web of Science ®Google Scholar
• O’Hara, A. M., and F. Shanahan. 2006. The gut flora as a forgotten organ. EMBO Reports 7 (7):688–93. doi: 10.1038/sj.embor.7400731.
   PubMed Web of Science ®Google Scholar
• Oh, J.-H., L. M. Alexander, M. Pan, K. L. Schueler, M. P. Keller, A. D. Attie, J. Walter, and J.-P. van Pijkeren. 2019. Dietary fructose and microbiota-derived short-chain fatty acids promote bacteriophage production in the gut symbiont Lactobacillus reuteri. Cell Host & Microbe 25 (2):273–84.e6. doi: 10.1016/j.chom.2018.11.016.
   PubMed Web of Science ®Google Scholar
• Öner, E. T., L. Hernández, and J. Combie. 2016. Review of Levan polysaccharide: From a century of past experiences to future prospects. Biotechnology Advances 34 (5):827–44. doi: 10.1016/j.biotechadv.2016.05.002.
   PubMed Web of Science ®Google Scholar
• Ouellette, A. J. 2011. Paneth cell α-defensins in enteric innate immunity. Cellular and Molecular Life Sciences 68 (13):2215–29. doi: 10.1007/s00018-011-0714-6.
   PubMed Web of Science ®Google Scholar
• Owyang, C., and G. D. Wu. 2014. The gut microbiome in health and disease. Gastroenterology 146 (6):1433–36. doi: 10.1053/j.gastro.2014.03.032.
   PubMed Web of Science ®Google Scholar
• Pabst, O., and M. Hornef. 2014. Gut microbiota: A natural adjuvant for vaccination. Immunity 41 (3):349–51. doi: 10.1016/j.immuni.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Palma, M. L., D. Zamith-Miranda, F. S. Martins, F. A. Bozza, L. Nimrichter, M. Montero-Lomeli, E. T. A. Marques, and B. Douradinha. 2015. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: Is there room for improvement? Applied Microbiology and Biotechnology 99 (16):6563–70. doi: 10.1007/s00253-015-6776-x.
   PubMed Web of Science ®Google Scholar
• Parfrey, L. W., W. A. Walters, and R. Knight. 2011. Microbial eukaryotes in the human microbiome: Ecology, evolution, and future directions. Frontiers in Microbiology 2:153. 2 doi: 10.3389/fmicb.2011.00153.
   PubMed Web of Science ®Google Scholar
• Park, C. B., H. S. Kim, and S. C. Kim. 1998. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochemical and Biophysical Research Communications 244 (1):253–7. doi: 10.1006/bbrc.1998.8159.
   PubMed Web of Science ®Google Scholar
• Parnell, J. A., T. Klancic, and R. A. Reimer. 2017. Oligofructose decreases serum lipopolysaccharide and plasminogen activator inhibitor-1 in adults with overweight/obesity. Obesity 25 (3):510–3. doi: 10.1002/oby.21763.
   PubMed Web of Science ®Google Scholar
• Parséus, A., N. Sommer, F. Sommer, R. Caesar, A. Molinaro, M. Ståhlman, T. U. Greiner, R. Perkins, and F. Bäckhed. 2017. Microbiota-induced obesity requires farnesoid X receptor. Gut 66 (3):429–37. doi: 10.1136/gutjnl-2015-310283.
   PubMed Web of Science ®Google Scholar
• Patel, S., and A. Goyal. 2012. The current trends and future perspectives of prebiotics research: A review. 3 Biotech 2 (2):115–25. doi: 10.1007/s13205-012-0044-x.
   Google Scholar
• Peterson, L. W., and D. Artis. 2014. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nature Reviews Immunology 14 (3):141–53. doi: 10.1038/nri3608.
   PubMed Web of Science ®Google Scholar
• Picard, C., J. Fioramonti, A. Francois, T. Robinson, F. Neant, and C. Matuchansky. 2005. Review article: Bifidobacteria as probiotic agents – Physiological effects and clinical benefits. Alimentary Pharmacology and Therapeutics 22 (6):495–512. doi: 10.1111/j.1365-2036.2005.02615.x.
   PubMed Web of Science ®Google Scholar
• Pietroiusti, A., A. Magrini, and L. Campagnolo. 2016. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials. Toxicology and Applied Pharmacology 299:90–5. doi: 10.1016/j.taap.2015.12.017.
   PubMed Web of Science ®Google Scholar
• Pinto-Alphandary, H., A. Andremont, and P. Couvreur. 2000. Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. International Journal of Antimicrobial Agents 13 (3):155–68. doi: 10.1016/S0924-8579(99)00121-1.
   PubMed Web of Science ®Google Scholar
• Plovier, H., A. Everard, C. Druart, C. Depommier, M. Van Hul, L. Geurts, J. Chilloux, N. Ottman, T. Duparc, L. Lichtenstein, et al. 2017. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine 23 (1):107–13. doi: 10.1038/nm.4236.
   PubMed Web of Science ®Google Scholar
• Pompei, A., L. Cordisco, A. Amaretti, S. Zanoni, D. Matteuzzi, and M. Rossi. 2007. Folate production by bifidobacteria as a potential probiotic property. Applied and Environmental Microbiology 73 (1):179–85. doi: 10.1128/AEM.01763-06.
   PubMed Web of Science ®Google Scholar
• Pulikkan, J., A. Maji, D. B. Dhakan, R. Saxena, B. Mohan, M. M. Anto, N. Agarwal, T. Grace, and V. K. Sharma. 2018. Gut microbial dysbiosis in Indian children with autism spectrum disorders. Microbial Ecology 76 (4):1102–14. doi: 10.1007/s00248-018-1176-2.
   PubMed Web of Science ®Google Scholar
• Pursey, E., D. Sünderhauf, W. H. Gaze, E. R. Westra, and S. van Houte. 2018. CRISPR-Cas antimicrobials: Challenges and future prospects. PLoS Pathogens 14 (6):e1006990. doi: 10.1371/journal.ppat.1006990.
   PubMed Web of Science ®Google Scholar
• Pushparaj Selvadoss, P., J. Nellore, M. Balaraman Ravindrran, U. Sekar, and J. Tippabathani. 2018. Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa. Artificial Cells, Nanomedicine, and Biotechnology 46 (2):268–73. doi: 10.1080/21691401.2017.1307209.
   PubMed Web of Science ®Google Scholar
• Qin, J., Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, D. Shen, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (7418):55–60. doi: 10.1038/nature11450.
   PubMed Web of Science ®Google Scholar
• Quévrain, E., M. A. Maubert, C. Michon, F. Chain, R. Marquant, J. Tailhades, S. Miquel, L. Carlier, L. G. Bermúdez-Humarán, B. Pigneur, et al. 2016. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut 65 (3):415–25. doi: 10.1136/gutjnl-2014-307649.
   PubMed Web of Science ®Google Scholar
• Rajakumar, P., A. Thirunarayanan, and S. Raja. 2014. Synthesis and antibacterial activity of novel N-methyl pyrrolidine dendrimers via [3 + 2] cycloaddition. Proceedings of the National Academy of Sciences India Section A - Physical Sciences. doi: 10.1007/s40010-013-0120-6.
   Google Scholar
• Rastall, R. A., and G. R. Gibson. 2015. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Current Opinion in Biotechnology 32:42–6. doi: 10.1016/j.copbio.2014.11.002.
   PubMed Web of Science ®Google Scholar
• Rebello, D., E. Wang, E. Yen, P. A. Lio, and C. R. Kelly. 2017. Hair growth in two alopecia patients after fecal microbiota transplant. ACG Case Reports Journal 4 (1):e107. doi: 10.14309/crj.2017.107.
   PubMedGoogle Scholar
• Reid, G. 2016. Probiotics: Definition, scope and mechanisms of action. Best Practice and Research: Clinical Gastroenterology 30 (1):17–25. doi: 10.1016/j.bpg.2015.12.001.
   PubMed Web of Science ®Google Scholar
• Rena, G., D. G. Hardie, and E. R. Pearson. 2017. The mechanisms of action of metformin. Diabetologia 60 (9):1577–85. doi: 10.1007/s00125-017-4342-z.
   PubMed Web of Science ®Google Scholar
• Rinninella, E., P. Raoul, M. Cintoni, F. Franceschi, G. Miggiano, A. Gasbarrini, and M. Mele. 2019. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7 (1):14. doi: 10.3390/microorganisms7010014.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Morató, J., N. R. Matthan, J. Liu, R. de la Torre, and C. Y. O. Chen. 2018. Cranberries attenuate animal-based diet-induced changes in microbiota composition and functionality: A randomized crossover controlled feeding trial. Journal of Nutritional Biochemistry 62:76–86. doi: 10.1016/j.jnutbio.2018.08.019.
   PubMed Web of Science ®Google Scholar
• Rogers, M. A. M., and D. M. Aronoff. 2016. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clinical Microbiology and Infection 22 (2):178.e1–9. doi: 10.1016/j.cmi.2015.10.003.
   Google Scholar
• Rohlke, F., and N. Stollman. 2012. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therapeutic Advances in Gastroenterology 5 (6):403–20. doi: 10.1177/1756283X12453637.
   PubMed Web of Science ®Google Scholar
• Roopchand, D. E., R. N. Carmody, P. Kuhn, K. Moskal, P. Rojas-Silva, P. J. Turnbaugh, and I. Raskin. 2015. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64 (8):2847–58. doi: 10.2337/db14-1916.
   PubMed Web of Science ®Google Scholar
• Rossen, N. G., MacDonald, J. K. E. M. De Vries, G. R. D’Haens, W. M. De Vos, and E. G. Zoetendal, Cyriel Y, Ponsioen. 2015. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World Journal of Gastroenterology 21 (17):5359. doi: 10.3748/wjg.v21.i17.5359.
   PubMed Web of Science ®Google Scholar
• Rossi, O., L. A. van Berkel, F. Chain, M. Tanweer Khan, N. Taverne, H. Sokol, S. H. Duncan, H. J. Flint, H. J. M. Harmsen, P. Langella, et al. 2016. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Scientific Reports 6 (1):18507. doi: 10.1038/srep18507.
   PubMedGoogle Scholar
• Round, J. L., S. M. Lee, J. Li, G. Tran, B. Jabri, T. A. Chatila, and S. K. Mazmanian. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (6032):974–77. doi: 10.1126/science.1206095.
   PubMed Web of Science ®Google Scholar
• Round, J. L., and S. K. Mazmanian. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America 107 (27):12204–9. doi: 10.1073/pnas.0909122107.
   PubMed Web of Science ®Google Scholar
• Rui, P., and T. Okeyode. 2015. National Ambulatory Medical Care Survey: 2015 State and National Summary Tables. https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2015_namcs_web_tables.pdf.
   Google Scholar
• Salmond, G. P. C., and P. C. Fineran. 2015. A century of the phage: Past, present and future. Nature Reviews Microbiology 13 (12):777–86. doi: 10.1038/nrmicro3564.
   PubMed Web of Science ®Google Scholar
• Saltzman, E. T., T. Palacios, M. Thomsen, and L. Vitetta. 2018. Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease. Frontiers in Microbiology 9:61. doi: 10.3389/fmicb.2018.00061.
   PubMed Web of Science ®Google Scholar
• Santiago-García, P. A., and M. G. López. 2014. Agavins from Agave angustifolia and Agave potatorum affect food intake, body weight gain and satiety-related hormones (GLP-1 and ghrelin) in mice. Food and Function 5 (12):3311–9. doi: 10.1039/c4fo00561a.
   PubMed Web of Science ®Google Scholar
• Savignac, H. M., M. Tramullas, B. Kiely, T. G. Dinan, and J. F. Cryan. 2015. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behavioural Brain Research 287:59–72. doi: 10.1016/j.bbr.2015.02.044.
   PubMed Web of Science ®Google Scholar
• Scarpellini, E., G. Ianiro, F. Attili, C. Bassanelli, A. De Santis, and A. Gasbarrini. 2015. The human gut microbiota and virome: Potential therapeutic implications. Digestive and Liver Disease 47 (12):1007–12. doi: 10.1016/j.dld.2015.07.008.
   Web of Science ®Google Scholar
• Scibilia, S., G. Lentini, E. Fazio, D. Franco, F. Neri, A. M. Mezzasalma, and S. P. P. Guglielmino. 2016. Self-assembly of silver nanoparticles and bacteriophage. Sensing and Bio-Sensing Research 7:146–52. doi: 10.1016/j.sbsr.2016.02.002.
   Google Scholar
• Scott, K. P., S. W. Gratz, P. O. Sheridan, H. J. Flint, and S. H. Duncan. 2013. The influence of diet on the gut microbiota. Pharmacological Research 69 (1):52–60. doi: 10.1016/j.phrs.2012.10.020.
   PubMed Web of Science ®Google Scholar
• Sekelja, M., I. Berget, T. Naes, and K. Rudi. 2011. Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach. The ISME Journal 5 (3):519–31. doi: 10.1038/ismej.2010.129.
   PubMed Web of Science ®Google Scholar
• Sekhon, B. S. 2010. Food nanotechnology – An overview. Nanotechnology, Science and Applications 3:1–15. doi: 10.2147/NSA.S8677.
   PubMedGoogle Scholar
• Sekirov, I., N. M. Tam, M. Jogova, M. L. Robertson, Y. Li, C. Lupp, and B. B. Finlay. 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infection and Immunity 76 (10):4726–36. doi: 10.1128/IAI.00319-08.
   PubMed Web of Science ®Google Scholar
• Sender, R., S. Fuchs, and R. Milo. 2016. Revised estimates for the number of human and bacteria cells in the body. PLOS Biology 14 (8):e1002533. doi: 10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Shader, R. I. 2015. Diabetes, more on merde, the microbiome, and the dung beetle. Clinical Therapeutics 37 (6):1147–49. doi: 10.1016/j.clinthera.2015.05.008.
   PubMed Web of Science ®Google Scholar
• Shapira, M. 2016. Gut microbiotas and host evolution: Scaling up symbiosis. Trends in Ecology and Evolution 31 (7):539–49. doi: 10.1016/j.tree.2016.03.006.
   PubMed Web of Science ®Google Scholar
• Sheu, B. S., J. J. Wu, C. Y. Lo, H. W. Wu, J. H. Chen, Y. S. Lin, and M. D. Lin. 2002. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 16 (9):1669–75. doi: 10.1046/j.1365-2036.2002.01335.x.
   PubMed Web of Science ®Google Scholar
• Shin, J. H., M. H. Nam, H. Lee, J. S. Lee, H. Kim, M. J. Chung, and J. G. Seo. 2018. Amelioration of obesity-related characteristics by a probiotic formulation in a high-fat diet-induced obese rat model. European Journal of Nutrition 57 (6):2081–90. doi: 10.1007/s00394-017-1481-4.
   PubMed Web of Science ®Google Scholar
• Shin, N.-R., J.-C. Lee, H.-Y. Lee, M.-S. Kim, T. Woong Whon, M.-S. Lee, and J.-W. Bae. 2014. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (5):727–35. doi: 10.1136/gutjnl-2012-303839.
   PubMed Web of Science ®Google Scholar
• Siró, I., E. Kápolna, B. Kápolna, and A. Lugasi. 2008. Functional food. Product development, marketing and consumer acceptance – A review. Appetite 51 (3):456–67. doi: 10.1016/j.appet.2008.05.060.
   PubMed Web of Science ®Google Scholar
• Smilowitz, J. T., C. B. Lebrilla, D. A. Mills, J. B. German, and S. L. Freeman. 2014. Breast milk oligosaccharides: Structure-function relationships in the neonate. Annual Review of Nutrition 34 (1):143–69. doi: 10.1146/annurev-nutr-071813-105721.
   PubMedGoogle Scholar
• Smith, A. M., M. A. Mthanti, C. Haumann, N. Tyalisi, G. P. G. Boon, A. Sooka, K. H. Keddy, and D. J. Diekema. 2014. Nosocomial outbreak of Salmonella enterica serovar Typhimurium primarily affecting a pediatric ward in South Africa in 2012. Journal of Clinical Microbiology 52 (2):627–31. doi: 10.1128/JCM.02422-13.
   PubMed Web of Science ®Google Scholar
• Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glickman, and W. S. Garrett. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Tregcell homeostasis. Science 341 (6145):569–73. doi: 10.1126/science.1241165.
   PubMed Web of Science ®Google Scholar
• Sokol, H., B. Pigneur, L. Watterlot, O. Lakhdari, L. G. Bermudez-Humaran, J.-J. Gratadoux, S. Blugeon, C. Bridonneau, J.-P. Furet, G. Corthier, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences 105 (43):16731–6. doi: 10.1073/pnas.0804812105.
   PubMed Web of Science ®Google Scholar
• Sonnenborn, U. 2016. Escherichia coli strain Nissle 1917-from bench to bedside and back: History of a special Escherichia coli strain with probiotic properties. FEMS Microbiology Letters 363 (19):fnw212. doi: 10.1093/femsle/fnw212.
   PubMed Web of Science ®Google Scholar
• Spindler, E. C., J. D. F. Hale, T. H. Giddings, R. E. W. Hancock, and R. T. Gill. 2011. Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrobial Agents and Chemotherapy 55 (4):1706–16. doi: 10.1128/AAC.01053-10.
   PubMed Web of Science ®Google Scholar
• Stern, A., E. Mick, I. Tirosh, O. Sagy, and R. Sorek. 2012. CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Research 22 (10):1985–94. doi: 10.1101/gr.138297.112.
   PubMed Web of Science ®Google Scholar
• Strati, F., D. Cavalieri, D. Albanese, C. De Felice, C. Donati, J. Hayek, O. Jousson, S. Leoncini, D. Renzi, A. Calabrò, et al. 2017. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5 (1):24. doi: 10.1186/s40168-017-0242-1.
   PubMed Web of Science ®Google Scholar
• Suau, A., V. Rochet, A. Sghir, G. Gramet, S. Brewaeys, M. Sutren, L. Rigottier-Gois, and J. Doré. 2001. Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Systematic and Applied Microbiology 24 (1):139–45. doi: 10.1078/0723-2020-00015.
   PubMed Web of Science ®Google Scholar
• Tamburini, S., N. Shen, H. C. Wu, and J. C. Clemente. 2016. The microbiome in early life: Implications for health outcomes. Nature Medicine 22 (7):713–22. doi: 10.1038/nm.4142.
   PubMed Web of Science ®Google Scholar
• Taylor, A. A., I. M. Marcus, R. L. Guysi, and S. L. Walker. 2015. Metal oxide nanoparticles induce minimal phenotypic changes in a model colon gut microbiota. Environmental Engineering Science 32 (7):602–12. doi: 10.1089/ees.2014.0518.
   Web of Science ®Google Scholar
• Ten Bruggencate, S. J. M., S. A. Girard, E. G. M. Floris-Vollenbroek, R. Bhardwaj, and T. A. Tompkins. 2014. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study. European Journal of Clinical Nutrition 69:385. doi: 10.1038/ejcn.2014.238.
   PubMed Web of Science ®Google Scholar
• Thamphiwatana, S., W. Gao, M. Obonyo, and L. Zhang. 2014. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation. Proceedings of the National Academy of Sciences 111 (49):17600–5. doi: 10.1073/pnas.1418230111.
   PubMed Web of Science ®Google Scholar
• The Human Microbiome Project Consortium, Huttenhower, C., D. Gevers, R. Knight, S. Abubucker, J. H. Badger, and A. T. Chinwalla. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207. doi: 10.1038/nature11234.
   PubMed Web of Science ®Google Scholar
• Thuny, F., H. Richet, J. P. Casalta, E. Angelakis, G. Habib, and D. Raoult. 2010. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 5 (2):e9074. doi: 10.1371/journal.pone.0009074.
   PubMed Web of Science ®Google Scholar
• Ticinesi, A., C. Milani, F. Lauretani, A. Nouvenne, L. Mancabelli, G. A. Lugli, F. Turroni, S. Duranti, M. Mangifesta, A. Viappiani, et al. 2017. Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients. Scientific Reports 7 (1):11102. doi: 10.1038/s41598-017-10734-y.
   PubMed Web of Science ®Google Scholar
• Topolska, K., R. Piotr Radzki, A. Filipiak-Florkiewicz, A. Florkiewicz, T. Leszczyńska, and E. Cieślik. 2018. Fructan-enriched diet increases bone quality in female growing rats at calcium deficiency. Plant Foods for Human Nutrition 73 (3):172–9. doi: 10.1007/s11130-018-0671-4.
   PubMed Web of Science ®Google Scholar
• Torres-Barceló, C. 2018. The disparate effects of bacteriophages on antibiotic-resistant bacteria. Emerging Microbes & Infections 7 (1):168. doi: 10.1038/s41426-018-0169-z.
   PubMedGoogle Scholar
• Trompette, A., E. S. Gollwitzer, K. Yadava, A. K. Sichelstiel, N. Sprenger, C. Ngom-Bru, C. Blanchard, T. Junt, L. P. Nicod, N. L. Harris, et al. 2014. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nature Medicine 20 (2):159–66. doi: 10.1038/nm.3444.
   PubMed Web of Science ®Google Scholar
• Tropini, C., K. A. Earle, K. C. Huang, and J. L. Sonnenburg. 2017. The gut microbiome: Connecting spatial organization to function. Cell Host and Microbe 21 (4):433–42. doi: 10.1016/j.chom.2017.03.010.
   PubMed Web of Science ®Google Scholar
• Trosvik, P., and E. T. de Muinck. 2015. Ecology of bacteria in the human gastrointestinal tract–identification of keystone and foundation taxa. Microbiome 3 (1):44. doi: 10.1186/s40168-015-0107-4.
   PubMedGoogle Scholar
• Turnbaugh, P. J., V. K. Ridaura, J. J. Faith, F. E. Rey, R. Knight, and J. I. Gordon. 2009. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine 1 (6):6ra14. doi: 10.1126/scitranslmed.3000322.
   PubMed Web of Science ®Google Scholar
• Turpin, W., C. Humblot, M. Thomas, and J.-P. Guyot. 2010. Lactobacilli as multifaceted probiotics with poorly disclosed molecular mechanisms. International Journal of Food Microbiology 143 (3):87–102. doi: 10.1016/j.ijfoodmicro.2010.07.032.
   PubMed Web of Science ®Google Scholar
• Ul Haq, I., W. N. Chaudhry, M. N. Akhtar, S. Andleeb, and I. Qadri. 2012. Bacteriophages and their implications on future biotechnology: A review. Virology Journal 9:9. doi: 10.1186/1743-422X-9-9.
   PubMed Web of Science ®Google Scholar
• Valles-Colomer, M., G. Falony, Y. Darzi, E. F. Tigchelaar, J. Wang, R. Y. Tito, C. Schiweck, A. Kurilshikov, M. Joossens, C. Wijmenga, et al. 2019. The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology 4 (4):623–32. doi: 10.1038/s41564-018-0337-x.
   PubMed Web of Science ®Google Scholar
• van der Aa Kühle, A., K. Skovgaard, and L. Jespersen. 2005. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. International Journal of Food Microbiology 101 (1):29–39. doi: 10.1007/BF02848203.
   PubMed Web of Science ®Google Scholar
• Vandenplas, Y., T. Ludwig, H. Bouritius, P. Alliet, D. Forde, S. Peeters, F. Huet, and J. Hourihane. 2017. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic. Acta Paediatrica 106 (7):1150–8. doi: 10.1111/apa.13844.
   PubMed Web of Science ®Google Scholar
• Vandeputte, D., G. Falony, S. Vieira-Silva, J. Wang, M. Sailer, S. Theis, K. Verbeke, and J. Raes. 2017. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut 66 (11):1968–74. doi: 10.1136/gutjnl-2016-313271.
   PubMed Web of Science ®Google Scholar
• Vane, J. R., and R. M. Botting. 2003. The mechanism of action of aspirin. Thrombosis Research 110 (5–6):255–8. doi: 10.1016/S0049-3848(03)00379-7.
   PubMed Web of Science ®Google Scholar
• van Nood, E., A. Vrieze, M. Nieuwdorp, S. Fuentes, E. G. Zoetendal, W. M. de Vos, C. E. Visser, E. J. Kujiper, J. F. W. M. Bartelsman, J. G. P. Tijssen, et al. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. New England Journal of Medicine 368:407–15. doi: 10.1056/NEJMoa1205037.
   PubMed Web of Science ®Google Scholar
• Villarino, N. F., G. R. LeCleir, J. E. Denny, S. P. Dearth, C. L. Harding, S. S. Sloan, J. L. Gribble, S. R. Campagna, S. W. Wilhelm, and N. W. Schmidt. 2016. Composition of the gut microbiota modulates the severity of malaria. Proceedings of the National Academy of Sciences 113 (8):2235–40. doi: 10.1073/pnas.1504887113.
   PubMed Web of Science ®Google Scholar
• Vrieze, A., E. Van Nood, F. Holleman, J. Salojärvi, R. S. Kootte, J. F. W. M. Bartelsman, G. M. Dallinga–Thie, M. T. Ackermans, M. J. Serlie, R. Oozeer, et al. 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (4):913–6.e7. doi: 10.1053/j.gastro.2012.06.031.
   PubMed Web of Science ®Google Scholar
• Wang, C., M. Q. Wang, S. S. Ye, W. J. Tao, and Y. J. Du. 2011. Effects of copper-loaded chitosan nanoparticles on growth and immunity in broilers. Poultry Science 90 (10):2223–8. doi: 10.3382/ps.2011-01511.
   PubMed Web of Science ®Google Scholar
• Wang, E. C., and A. Z. Wang. 2014. Nanoparticles and their applications in cell and molecular biology. Integrative Biology (United Kingdom) 6 (1):9–26. doi: 10.1039/c3ib40165k.
   PubMed Web of Science ®Google Scholar
• Wang, K. Y., S. N. Li, C. S. Liu, D. S. Perng, Y. C. Su, D. C. Wu, C. M. Jan, C. H. Lai, T. N. Wang, and W. M. Wang. 2004. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. American Journal of Clinical Nutrition 80 (3):737–41. doi: 10.1093/ajcn/80/3/737.
   PubMed Web of Science ®Google Scholar
• Wang, M. Q., Y. J. Du, C. Wang, W. J. Tao, Y. D. He, and H. Li. 2012. Effects of copper-loaded chitosan nanoparticles on intestinal microflora and morphology in weaned piglets. Biological Trace Element Research 149 (2):184–9. doi: 10.1007/s12011-012-9410-0.
   PubMed Web of Science ®Google Scholar
• Wegner, K. D., and N. Hildebrandt. 2015. Quantum dots: Bright and versatile in vitro and in vivo fluorescence imaging biosensors. Chemical Society Reviews 44 (14):4792–834. doi: 10.1039/C4CS00532E.
   PubMed Web of Science ®Google Scholar
• Wehkamp, J., J. Harder, K. Wehkamp, B. Wehkamp-von Meissner, M. Schlee, C. Enders, U. Sonnenborn, S. Nuding, S. Bengmark, K. Fellermann, et al. 2004. NF-ΚB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium. Infection and Immunity 72 (10):5750–8. doi: 10.1128/IAI.72.10.5750-5758.2004.
   PubMed Web of Science ®Google Scholar
• Weil, A. A., and E. L. Hohmann. 2015. Fecal microbiota transplant: Benefits and risks. Open Forum Infectious Diseases 2 (1):ofv005. doi: 10.1093/ofid/ofv005.
   PubMed Web of Science ®Google Scholar
• Wen, L., R. E. Ley, P. Y. Volchkov, P. B. Stranges, L. Avanesyan, A. C. Stonebraker, C. Hu, F. S. Wong, G. L. Szot, J. A. Bluestone, et al. 2008. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455 (7216):1109–13. doi: 10.1038/nature07336.
   PubMed Web of Science ®Google Scholar
• WHO. 2012. The pursuit of responsible use of medicines: Sharing and learning from country experiences. Geneva: World Health Organization. doi: 10.1136/vr.d5420.
   Google Scholar
• Wijnands, L. M., J. B. Dufrenne, F. M. Van Leusden, and T. Abee. 2007. Germination of Bacillus cereus spores is induced by germinants from differentiated Caco-2 cells, a human cell line mimicking the epithelial cells of the small intestine. Applied and Environmental Microbiology 73 (15):5052–4. doi: 10.1128/AEM.02390-06.
   PubMed Web of Science ®Google Scholar
• Wrzosek, L., S. Miquel, M.-L. Noordine, S. Bouet, M. Chevalier-Curt, V. Robert, C. Philippe, C. Bridonneau, C. Cherbuy, C. Robbe-Masselot, et al. 2013. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biology 11 (1):61. doi: 10.1186/1741-7007-11-61.
   PubMedGoogle Scholar
• Wu, G. D., J. Chen, C. Hoffmann, K. Bittinger, Y. Y. Chen, S. A. Keilbaugh, M. Bewtra, D. Knights, W. A. Walters, R. Knight, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (6052):105–8. doi: 10.1126/science.1208344.
   PubMed Web of Science ®Google Scholar
• Wu, H.-J., I. I. Ivanov, J. Darce, K. Hattori, T. Shima, Y. Umesaki, D. R. Littman, C. Benoist, and D. Mathis. 2010. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32 (6):815–27. doi: 10.1016/j.immuni.2010.06.00.
   PubMed Web of Science ®Google Scholar
• Wypych, T. P., and B. J. Marsland. 2018. Antibiotics as instigators of microbial dysbiosis: Implications for asthma and allergy. Trends in Immunology 39 (9):697–711. doi: 10.1016/j.it.2018.02.008.
   PubMed Web of Science ®Google Scholar
• Xiao, X., G. Nakatsu, Y. Jin, S. Wong, J. Yu, and J. Y. W. Lau. 2017. Gut microbiota mediates protection against enteropathy induced by indomethacin. Scientific Reports 7 (1):40317. doi: 10.1038/srep40317.
   PubMedGoogle Scholar
• Yamada, T., D. Takahashi, and K. Hase. 2016. The diet-microbiota-metabolite axis regulates the host physiology. Journal of Biochemistry 160 (1):1–10. doi: 10.1093/jb/mvw022.
   PubMed Web of Science ®Google Scholar
• Yang, J., P. H. Summanen, S. M. Henning, M. Hsu, H. Lam, J. Huang, C.-H. Tseng, S. E. Dowd, S. M. Finegold, D. Heber, et al. 2015. Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: A pilot study. Frontiers in Physiology 6:216. doi: 10.3389/fphys.2015.00216.
   PubMed Web of Science ®Google Scholar
• Yang, Y.-X., and D. C. Metz. 2010. Safety of proton pump inhibitor exposure. Gastroenterology 139 (4):1115–27. doi: 10.1053/j.gastro.2010.08.023.
   PubMed Web of Science ®Google Scholar
• You, J., Y. Zhang, and Z. Hu. 2011. Bacteria and bacteriophage inactivation by silver and zinc oxide nanoparticles. Colloids and Surfaces B: Biointerfaces 85 (2):161–7. doi: 10.1016/j.colsurfb.2011.02.023.
   PubMed Web of Science ®Google Scholar
• Zackular, J. P., N. T. Baxter, G. Y. Chen, and P. D. Schloss. 2015. Manipulation of the gut microbiota reveals role in colon tumorigenesis. MSphere 1 (1):e00001-15. doi: 10.1128/mSphere.00001-15.
   PubMed Web of Science ®Google Scholar
• Zackular, J. P., N. T. Baxter, K. D. Iverson, W. D. Sadler, J. F. Petrosino, G. Y. Chen, and P. D. Schloss. 2013. The gut microbiome modulates colon tumorigenesis. MBio 4 (6):e00692-13. doi: 10.1128/mBio.00692-13.
   PubMed Web of Science ®Google Scholar
• Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415 (6870):389–95. doi: 10.1038/415389a.
   PubMed Web of Science ®Google Scholar
• Zhang, M., J. R. Chekan, D. Dodd, P.-Y. Hong, L. Radlinski, V. Revindran, S. K. Nair, R. I. Mackie, and I. Cann. 2014. Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. Proceedings of the National Academy of Sciences 111 (35):E3708-17. doi: 10.1073/pnas.1406156111.
   PubMed Web of Science ®Google Scholar
• Zhang, M., K. Sun, Y. Wu, Y. Yang, P. Tso, and Z. Wu. 2017. Interactions between intestinal microbiota and host immune response in inflammatory bowel disease. Frontiers in Immunology 8:942. doi: 10.3389/fimmu.2017.00942.
   PubMed Web of Science ®Google Scholar
• Zimmermann, P., and N. Curtis. 2018. The influence of the intestinal microbiome on vaccine responses. Vaccine 36 (30):4433–39. doi: 10.1016/j.vaccine.2018.04.066.
   PubMed Web of Science ®Google Scholar
• Zou, S. L., Fang, and M. H. Lee. 2018. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterology Report 6 (1):1–12. doi: 10.1093/gastro/gox031.
   PubMed Web of Science ®Google Scholar